×
GETINGE EBIT 2016-2024 | GNGBY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
GETINGE ebit from 2016 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
GETINGE EBIT 2016-2024 | GNGBY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
GETINGE ebit from 2016 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$93.4B
Cencora (COR)
$48.3B
DiDi Global (DIDIY)
$22.2B
Natera (NTRA)
$22.1B
ICON (ICLR)
$17.7B
Viatris (VTRS)
$16B
Avantor (AVTR)
$14.1B
Revvity (RVTY)
$13.6B
CochLear (CHEOY)
$12.8B
Solventum (SOLV)
$12.2B
BioMerieux (BMXMF)
$11.9B
Medpace Holdings (MEDP)
$10.5B
Charles River Laboratories (CRL)
$10B
HealthEquity (HQY)
$9.1B
Doximity (DOCS)
$9B
Sonic Healthcare (SKHHY)
$8.9B
Bausch + Lomb (BLCO)
$6.9B
Life Times (LTH)
$5.1B
Organon (OGN)
$3.9B
Sotera Health (SHC)
$3.6B
BrightSpring Health Services (BTSG)
$3.3B
Surgery Partners (SGRY)
$2.9B
Concentras Parent (CON)
$2.8B
PACS (PACS)
$2.5B
Alignment Healthcare (ALHC)
$2.3B
Ardent Health Partners (ARDT)
$2.3B
Premier (PINC)
$2.2B
GeneDx Holdings (WGS)
$2.2B
Ryman Healthcare (RYHTY)
$2B
GoodRx Holdings (GDRX)
$1.9B